Cure My Disease

Don't miss your cure!

 Log in / Sign up

Protein's role in prolonged ICU stays under the microscope

NCT ID NCT07268274

Knowledge-focused Sponsor: Universidade do Algarve Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at 100 adults who have been in the intensive care unit (ICU) for more than a week and need a breathing machine. Researchers want to see how their bodies use energy and how protein intake affects their recovery. The goal is to learn more, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

100 people

The number who actually took part.

Started

Mar 2024

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study will include adult critically ill patients admitted to intensive care who meet the eligibility criteria described.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult critically ill patients admitted to Intensive Care Unit \> 7 days * Invasive mechanical ventilation (IMV) \> 48 hours Exclusion Criteria: * Active oncological disease * Neuromuscular diseases * Confirmed or predicted Glasgow Coma Score \< 10 at 14 days in Intensive Care Unit * Pregnant women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adult icu patients are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adult icu patients

Contacts and locations

Locations

  • Algarve

    Faro, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.